Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pars Behrouzan Jam is a prominent Iranian pharmaceutical company specializing in the importation, distribution, and marketing of high-value medicinal products and medical equipment. Founded in 2010 and headquartered in Tehran, the company focuses on critical therapeutic areas including oncology, hematology, nephrology, and rare diseases. PBJ serves as a vital link in the Iranian healthcare system by partnering with international manufacturers to supply life-saving treatments and specialized nutritional supplements. The organization operates a sophisticated distribution network that adheres to international quality standards and Good Distribution Practices (GDP), particularly for cold-chain products. In addition to its commercial activities, the company has expanded into local manufacturing to enhance domestic pharmaceutical self-sufficiency.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pars Behrouzan Jam.